Literature DB >> 11175286

Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3'A, CCR2-641, and CCR5-delta32) in global populations.

B Su1, G Sun, D Lu, J Xiao, F Hu, R Chakraborty, R Deka, L Jin.   

Abstract

Chemokine receptors (CCR5, CXCR4 and CCR2) have been shown to be important co-receptors for HIV infection. Mutations at CCR5 (CCR5-delta2), CCR2 (CCR2-641), and stromal-derived factor SDF1 (SDF1-3'A), a primary ligand for CXCR4, are known to have protective effects against HIV-1 infection and the onset of AIDS symptoms. We studied the three-locus genotype frequency distributions in 70worldwide populations from a sample of 2341 individuals without any known history of HIV-1 infection and AIDS symptoms. From these data, we estimated the risk of AIDS onset (relative hazard, RH) of each population. This survey shows that the substantial allele frequency differences of each of these mutations translate into an extensive variation in relative hazards for AIDS in worldwide populations. However, no evidence of natural selection against the mutant gene carriers is detected. Finally, the combined three-locus genotype data predict the highest relative hazard (RH) in South-East Asia and Africa where AIDS is known to be more prevalent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11175286     DOI: 10.1038/sj.ejhg.5200568

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  24 in total

1.  Distribution of HIV-1 resistance-conferring polymorphic alleles SDF-1-3'A, CCR2-64I and CCR5-Delta32 in diverse populations of Andhra Pradesh, South India.

Authors:  G V Ramana; A Vasanthi; M Khaja; B Su; V Govindaiah; L Jin; L Singh; R Chakraborty
Journal:  J Genet       Date:  2001-12       Impact factor: 1.166

2.  Genetic factors associated with slow progression of HIV among perinatally-infected Indian children.

Authors:  Riya Pal Chaudhuri; Ujjwal Neogi; Shwetha D Rao; Anita Shet
Journal:  Indian Pediatr       Date:  2014-10       Impact factor: 1.411

Review 3.  The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression.

Authors:  C Farquhar; G John-Stewart
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

4.  Examination of ancestry and ethnic affiliation using highly informative diallelic DNA markers: application to diverse and admixed populations and implications for clinical epidemiology and forensic medicine.

Authors:  Nan Yang; Hongzhe Li; Lindsey A Criswell; Peter K Gregersen; Marta E Alarcon-Riquelme; Rick Kittles; Russell Shigeta; Gabriel Silva; Pragna I Patel; John W Belmont; Michael F Seldin
Journal:  Hum Genet       Date:  2005-09-29       Impact factor: 4.132

5.  The Indian genetic landscape and disease-related genes.

Authors:  Evelyne Heyer
Journal:  J Biosci       Date:  2008-12       Impact factor: 1.826

6.  The Distribution of CCR2-64I, SDF1-3'A and MCP1-2518 G/A Genes Polymorphism in a Specific High Risk Group from the Northeastern States West Bengal, and Gorkha Population in India.

Authors:  Partha Roy; Sekhar Chakrabarti
Journal:  Indian J Virol       Date:  2012-09-12

Review 7.  Human Genetic Variation and HIV/AIDS in Papua New Guinea: Time to Connect the Dots.

Authors:  Rajeev K Mehlotra
Journal:  Curr HIV/AIDS Rep       Date:  2018-12       Impact factor: 5.071

8.  Allelic distribution of the CCR5, CCR2, and SDF1 gene polymorphisms associated with HIV-1/AIDS resistance in Russian populations.

Authors:  I A Kofiadi; D V Rebrikov; D Yu Trofimov; L P Alexeev; R M Khaitov
Journal:  Dokl Biol Sci       Date:  2007 Jul-Aug

Review 9.  Targeting CCR5 for anti-HIV research.

Authors:  W-G Gu; X-Q Chen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-11       Impact factor: 3.267

10.  The Consequence of a Founder Effect: CCR5-∆32, CCR2-64I and SDF1-3'A Polymorphism in Vlach Gypsy Population in Hungary.

Authors:  Emese Juhász; Judit Béres; Szilvia Kanizsai; Károly Nagy
Journal:  Pathol Oncol Res       Date:  2011-06-11       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.